Authors:
Wiley, MR
Weir, LC
Briggs, S
Bryan, NA
Buben, J
Campbell, C
Chirgadze, NY
Conrad, RC
Craft, TJ
Ficorilli, JV
Franciskovich, JB
Froelich, LL
Gifford-Moore, DS
Goodson, T
Herron, DK
Klimkowski, VJ
Kurz, KD
Kyle, JA
Masters, JJ
Ratz, AM
Milot, G
Shuman, RT
Smith, T
Smith, GF
Tebbe, AL
Tinsley, JM
Towner, RD
Wilson, A
Yee, YK
Citation: Mr. Wiley et al., Structure-based design of potent, amidine-derived inhibitors of factor Xa:Evaluation of selectivity, anticoagulant activity, and antithrombotic activity, J MED CHEM, 43(5), 2000, pp. 883-899
Authors:
Masters, JJ
Franciskovich, JB
Tinsley, JM
Campbell, C
Campbell, JB
Craft, TJ
Froelich, LL
Gifford-Moore, DS
Hay, LA
Herron, DK
Klimkowski, VJ
Kurz, KD
Metz, JT
Ratz, AM
Shuman, RT
Smith, GF
Smith, T
Towner, RD
Wiley, MR
Wilson, A
Yee, YK
Citation: Jj. Masters et al., Non-amidine-containing 1,2-dibenzamidobenzene inhibitors of human factor Xa with potent anticoagulant and antithrombotic activity, J MED CHEM, 43(11), 2000, pp. 2087-2092
Citation: Wt. Jackson et al., Pharmacologic actions of the second-generation leukotriene B-4 receptor antagonist LY293111: In vitro studies, J PHARM EXP, 288(1), 1999, pp. 286-294